NAVLE Urinary

Feline Kidney Lymphoma Study Guide

📅 March 28, 2026 ⏱ 25 min read

Renal lymphoma is the most common neoplasm affecting the feline kidney and represents approximately 3.6% of all feline lymphoma cases.

Overview and Clinical Importance

Renal lymphoma is the most common neoplasm affecting the feline kidney and represents approximately 3.6% of all feline lymphoma cases. This aggressive malignancy carries a guarded to poor prognosis, with median survival times of only 3-6 months even with treatment. Understanding renal lymphoma is critical for the NAVLE as it tests knowledge of oncology, nephrology, and emergency medicine simultaneously.

Renal lymphoma typically presents as bilateral disease (affecting both kidneys) and has a unique propensity to metastasize to the central nervous system, occurring in approximately 40% of cases. This CNS spread significantly worsens prognosis and complicates treatment decisions.

High-YieldApproximately 50% of cats with renal lymphoma test positive for Feline Leukemia Virus (FeLV). Always test for FeLV/FIV in suspected cases, as retroviral status affects prognosis and treatment decisions.

Parameter	Clinical Details
Age	Middle-aged to older cats (mean 8-10 years); younger cats more commonly FeLV-positive
Sex	Males may be slightly overrepresented
Breed	No strong breed predisposition; Domestic Shorthair most commonly affected (reflects population)
Incidence	3.6% of all feline lymphomas; 22.3% of large cell lymphomas
FeLV Status	Approximately 50% test positive for FeLV

Etiology and Pathophysiology

Viral Association

Historically, renal lymphoma was strongly associated with FeLV infection, with approximately 50% of affected cats testing positive. Since the implementation of widespread FeLV vaccination and testing programs, the overall incidence of FeLV-associated lymphomas has decreased. However, the kidney remains a common extranodal site for lymphoma development.

Cellular Origin and Immunophenotype

Renal lymphoma in cats is predominantly a large cell (high-grade) lymphoma. The majority of cases are B-cell lymphomas, though T-cell phenotypes can occur. Large cell lymphomas are characterized by aggressive behavior and rapid progression but are generally more responsive to chemotherapy than small cell (low-grade) lymphomas.

Pattern of Disease

Bilateral involvement: Renal lymphoma typically affects both kidneys simultaneously, though unilateral cases can occur. The neoplastic lymphocytes infiltrate and replace normal renal parenchyma, leading to progressive loss of kidney function.

Primary vs. Multicentric: Renal lymphoma can present as a primary (isolated to kidneys) or as part of multicentric disease with involvement of other organs. Studies indicate that approximately 50% of renal lymphoma cases have multicentric disease at diagnosis.

High-YieldCNS metastasis occurs in up to 40% of renal lymphoma cases. The proposed mechanism involves hematogenous spread through the renal vasculature to the CNS. This unique tropism for CNS spread distinguishes renal lymphoma from other anatomical forms.

Clinical Sign	Pathophysiologic Mechanism
Weight loss	Cancer cachexia, uremia-induced anorexia
Anorexia/Decreased appetite	Uremic toxins, nausea
Polyuria/Polydipsia	Loss of urine concentrating ability due to parenchymal infiltration
Vomiting	Uremic gastritis, accumulation of uremic toxins
Lethargy/Weakness	Anemia, uremia, general debilitation
Neurological signs	CNS metastasis: seizures, behavior changes, ataxia, paresis

Signalment and Epidemiology

NAVLE TipWhen a board question presents a middle-aged cat with bilateral renomegaly and azotemia, renal lymphoma should be high on your differential list, especially if the cat has risk factors like FeLV-positive status or presents with neurological signs.

Ultrasound Finding	Clinical Significance
Renomegaly	Present in 100% of cases; kidneys greater than 4.4 cm length
Hypoechoic subcapsular thickening	80% sensitivity; hypoechoic halo/band surrounding renal cortex; 85% specificity for lymphoma
Increased cortical echogenicity	Diffuse hyperechoic cortex; loss of normal corticomedullary distinction
Abnormal shape/contour	Irregular margins, lobulation, loss of normal bean shape
Pyelectasia	Mild renal pelvic dilation; may indicate infiltration
Hypoechoic masses/nodules	Focal or multifocal hypoechoic lesions within parenchyma

Clinical Signs and Physical Examination

Common Clinical Signs

Clinical signs of renal lymphoma reflect progressive kidney dysfunction and are often indistinguishable from other causes of chronic kidney disease:

Physical Examination Findings

Bilateral renomegaly: The hallmark finding; kidneys are often enlarged, irregular, and firm on palpation
Poor body condition: Muscle wasting, poor hair coat
Dehydration: Skin tenting, tacky mucous membranes
Pale mucous membranes: Non-regenerative anemia common
Lymphadenopathy: May indicate multicentric disease

High-YieldIf neurological signs (seizures, behavior changes, ataxia, paresis) develop in a cat being treated for renal lymphoma, suspect CNS metastasis. This occurs in up to 40% of cases and significantly worsens prognosis.

Protocol	Drugs	Notes
COP	Cyclophosphamide, Vincristine (Oncovin), Prednisolone	Common first-line; CR rates 33-75%
CHOP/L-CHOP	Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Vincristine, Prednisolone (+/- L-asparaginase)	CR rates 38-80%; MST 203 days
COAP	Cyclophosphamide, Vincristine, Cytosine arabinoside, Prednisolone	Includes CNS-penetrating agent
Prednisolone alone	Prednisolone 1-2 mg/kg PO q24h	Palliative; MST 50 days

Diagnostic Approach

Minimum Database

Complete Blood Count (CBC)

Non-regenerative anemia: Present in approximately 60% of cases; anemia of chronic disease
Leukocytosis or leukopenia: Variable; circulating atypical lymphocytes may be seen
Thrombocytopenia: May occur with bone marrow involvement

Serum Biochemistry

Azotemia: Elevated BUN and creatinine reflecting renal dysfunction
Hyperphosphatemia: Decreased renal phosphorus excretion
Hypokalemia: Common in cats with chronic kidney disease
Hypercalcemia: Less common than in canine lymphoma but can occur

Urinalysis

Isosthenuria (USG 1.008-1.012) or minimally concentrated urine
Inactive sediment typically (unless concurrent UTI)

Retroviral Testing

FeLV/FIV testing is mandatory in all cats with suspected lymphoma. FeLV-positive status is associated with poorer prognosis and may influence treatment decisions.

Diagnostic Imaging

Abdominal Radiography

Radiographic findings may include bilateral renomegaly with loss of normal kidney shape. However, radiography has limited sensitivity for detecting early or subtle renal changes.

Abdominal Ultrasonography (Preferred Imaging Modality)

Ultrasonography is the gold standard imaging modality for evaluating renal lymphoma. Key findings include:

NAVLE TipThe hypoechoic subcapsular thickening (halo sign) has 60.7% sensitivity and 84.6% specificity for renal lymphoma in cats. While not pathognomonic, it should raise high suspicion for lymphoma and prompt FNA cytology.

Computed Tomography (CT)

CT provides superior anatomical detail for staging. Renal lymphoma typically shows bilateral involvement, multiple lesions, and homogeneous enhancement patterns. CT is also useful for evaluating abdominal lymphadenopathy and potential CNS involvement.

Cytology and Histopathology

Fine-Needle Aspiration (FNA) Cytology

Ultrasound-guided FNA is the preferred diagnostic method for confirming renal lymphoma. It is minimally invasive and highly diagnostic when adequate samples are obtained.

Cytologic features of large cell lymphoma:

Monomorphic population of large lymphoid cells (greater than 2x size of RBC)
Lymphoblasts with large nuclei, open chromatin, prominent nucleoli
Basophilic cytoplasm, high nuclear-to-cytoplasmic ratio
Numerous mitotic figures
Lymphoglandular bodies (fragmented lymphocyte cytoplasm) in background

High-YieldWhen greater than 50% of cells on lymph node or organ aspirate are lymphoblasts, a cytologic diagnosis of lymphoma can be reliably made. Renal lymphoma typically exfoliates well, making FNA highly diagnostic.

Ancillary Testing

PARR (PCR for Antigen Receptor Rearrangement): Detects clonality; 68-90% sensitivity; useful when cytology is equivocal
Flow Cytometry: Determines immunophenotype (B-cell vs T-cell)
Immunohistochemistry: CD3 (T-cell), CD20/CD79a (B-cell) markers on biopsy samples

Treatment	Median Survival Time
No treatment	Days to weeks
Prednisolone alone	50 days (range 20-1027 days)
Multi-agent chemotherapy (COP/CHOP)	3-6 months; some cats may survive greater than 1 year
With CNS involvement	Significantly reduced; weeks

Staging

Complete staging is recommended to determine extent of disease and guide treatment decisions:

Complete blood count, serum biochemistry, urinalysis
FeLV/FIV testing
Thoracic radiographs (3 views) to evaluate for mediastinal involvement or metastases
Abdominal ultrasound with FNA of affected organs
Bone marrow aspirate (especially if cytopenias present)
Neurological examination (if CNS signs present, consider CSF analysis and MRI)

Differential	Distinguishing Features
Renal lymphoma	Bilateral, hypoechoic subcapsular thickening, cytology shows lymphoblasts
Polycystic kidney disease	Multiple anechoic cysts; Persian breed predisposition; hereditary
FIP (dry form)	Young cats, hyperglobulinemia, pyogranulomatous inflammation on histopathology
Renal cell carcinoma	Usually unilateral, solitary mass, heterogeneous enhancement on CT
Hydronephrosis	Anechoic dilated renal pelvis, often secondary to obstruction
Acute kidney injury	Kidneys may be normal to enlarged; history of toxin exposure (lily, ethylene glycol)

Treatment

Chemotherapy Protocols

Chemotherapy is the mainstay of treatment for renal lymphoma. Surgery (nephrectomy) is generally not recommended due to the bilateral nature of disease and presence of systemic involvement.

NAVLE TipUse CAUTION with doxorubicin in cats with renal lymphoma due to its potential nephrotoxicity. Many oncologists prefer COP or COAP protocols for renal lymphoma patients with pre-existing azotemia.

CNS Prophylaxis Considerations

Historically, cytosine arabinoside (cytarabine) was added to protocols for CNS prophylaxis due to its ability to cross the blood-brain barrier. However, recent studies suggest CNS metastasis may be less common than previously reported, and the necessity of CNS prophylaxis is now questioned.

Supportive Care

IV fluid therapy: Correct dehydration and support renal perfusion
Antiemetics: Maropitant, ondansetron for nausea/vomiting
Nutritional support: High-quality protein diet; appetite stimulants (mirtazapine)
Potassium supplementation: If hypokalemic
Phosphate binders: Aluminum hydroxide if hyperphosphatemic

Prognosis

Renal lymphoma carries a guarded to poor prognosis compared to other anatomical forms of feline lymphoma.

Prognostic Factors

FeLV status: FeLV-positive cats have poorer prognosis
Response to treatment: Cats achieving complete remission have longer survival
CNS involvement: Significantly worsens prognosis
Initial renal function: Severe azotemia at presentation may complicate treatment

High-YieldWhile azotemia and anemia at diagnosis were historically considered negative prognostic factors, recent studies have not found these to significantly impact survival. The best prognostic indicator is response to initial chemotherapy.

Differential Diagnosis

When presented with bilateral renomegaly in a cat, consider:

Memory Aids

RENAL-L = Renal Lymphoma Key Facts

R = Renomegaly (bilateral) - 100% of cases
E = Elevated BUN/creatinine (azotemia)
N = Neurological signs (40% get CNS spread)
A = Anemia (non-regenerative) in 60%
L = Large cell lymphoma (high-grade)
L = Leukemia virus (FeLV) positive in 50%

The 50-40-3 Rule:

50% are FeLV positive
40% develop CNS metastasis
3-6 months median survival with treatment

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →